Full text
5/2026
vol. 43
Original paper
Clinical efficacy of Q-switched alexandrite 755-nm laser combined with Nd:YAG 1064-nm laser in the treatment of café-au-lait macules
Department of Dermatology, Xijing Hospital, Fourth Military, Shaanxi, China
Adv Dermatol Allergol 2026; XLIII (5): 502-509
Data publikacji online: 2026/10/22
- Chen T, Wu J, Yang X, et al. Clinical characteristics of multiple cafe-au-lait macules and their potential significance in the early screening of genetic diseases. Clin Cosmet Investig Dermatol 2025; 18: 1339-47.
- Ruggiero JL, Dodds M, Freese R, et al. Cutaneous findings in Fanconi anemia. J Am Acad Dermatol 2021; 85: 1253-8.
- Zhang B, Chu Y, Xu Z, et al., Treatment of cafe-au-lait spots using q-switched alexandrite laser: analysis of clinical characteristics of 471 children in Mainland China. Lasers Surg Med 2019; 51: 694-700.
- Liu Y, Yang W, Ding Y, et al. Characteristics of skin lesions determine the therapeutic response of facial cafe au lait macules laser therapy. J Cosmet Dermatol 2025; 24: e70062.
- Zhong Z, Yang T, Liu S, et al. Case report: Gene mutation analysis and skin imaging of isolated cafe-au-lait macules. Front Genet 2023; 14: 1126555.
- Guo ZZ, Wang ZC, Wang D, et al. Laser treatment for Cafe-au-lait Macules: a systematic review and meta-analysis. Eur J Med Res 2023; 28: 185.
- Hur H, Baek JO, Joo JS, et al. The treatment of infantile giant cafe au lait spot using golden parameter therapy with a high fluence 1064-nm Q-switched Nd: YAG laser. J Dermatolog Treat 2024; 35: 2390081.
- Zhang AD, Clovie J, Lazar M, Vashi NA. Treatment of benign pigmented lesions using lasers: a scoping review. J Clin Med 2025; 14: 3985.
- Nistico SP, Sannino M, Fasano G, et al. Fractional Q-switched 1064 nm laser for treatment of atrophic scars in Asian skin. Medicina 2022; 58: 1190.
- Ruchiatan K, Suhada KU, Hindritiani R, et al. Combination of 1064 nm long-pulsed and Q-switched Nd:YAG laser for facial hypertrophic scar and hyperpigmentation following burn injury. Int Med Case Rep J 2022; 15: 23-7.
- Scott J, Huskisson EC. Graphic representation of pain. Pain 1976; 2: 175-84.
- Nasi L, Alexopoulos A, Kokkinou E, et al. Characteristics of cafe-au-lait macules and their association with the neurofibromatosis type i genotype in a cohort of Greek children. Acta Derm Venereol 2023; 103: adv5758.
- Santangelo A, Chelleri C, Toasino M, et al. Cafe-au-lait macules in neurofibromatosis type 1: birthmark or biomarker? Cancers 2025; 17: 1490.
- Shah A, Hawryluk EB, Seiverling EV. Dermoscopy aids in differentiating cafe-au-lait macules from congenital melanocytic nevi in patients with darker skin phototypes. Pediatr Dermatol 2025; 42: 212-5.
- Liu X, Liao C. Value of Q-switched 755-nm alexandrite laser combined with topical tranexamic acid in the treatment of melasma. Am J Transl Res 2025; 17: 1651-61.
- Dai R, Cao Y, Su Y, Cai S. Comparison of 1064-nm Nd:YAG picosecond laser using fractional micro-lens array vs. ablative fractional 2940-nm Er:YAG laser for the treatment of atrophic acne scar in Asians: a 20-week prospective, randomized, split-face, controlled pilot study. Front Med 2023; 10: 1248831.
- Zhang C, Saibaidula Y, Luo Y, Ou J. Typical presentation of neurofibromatosis type I in a patient with giant cutaneous neoplasm and cafe au lait spots: a case report. Biomed Rep 2025; 22: 27.
- Liang S, Shang S, Tan A, et al. Comparative efficacy and safety of the novel Picosecond Alexandrite Laser and the traditional combined Q-switched and long-pulse Nd: YAG lasers in melasma treatment: a randomized evaluator-blinded trial. Lasers Med Sci 2025; 40: 29.
- Li Y, Liu Y, Gao F, Jiang F. Bibliometric analysis of global research on cafe-au-lait macules from 2000 to 2025: development, collaboration patterns, and emerging trends. Clin Cosmet Investig Dermatol 2025; 18: 3239-55.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
